Please use this identifier to cite or link to this item:
|Title:||Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group.|
|Authors:||Kossoff, Eric H;Zupec-Kania, Beth A;Auvin, Stéphane;Ballaban-Gil, Karen R;Christina Bergqvist, A G;Blackford, Robyn;Buchhalter, Jeffrey R;Caraballo, Roberto H;Cross, J Helen;Dahlin, Maria G;Donner, Elizabeth J;Guzel, Orkide;Jehle, Rana S;Klepper, Joerg;Kang, Hoon-Chul;Lambrechts, Danielle A;Liu, Y M Christiana;Nathan, Janak K;Nordli, Douglas R;Pfeifer, Heidi H;Rho, Jong M;Scheffer, Ingrid E;Sharma, Suvasini;Stafstrom, Carl E;Thiele, Elizabeth A;Turner, Zahava;Vaccarezza, Maria M;van der Louw, Elles J T M;Veggiotti, Pierangelo;Wheless, James W;Wirrell, Elaine C|
|Affiliation:||Department of Paediatrics Alberta Children's Hospital Calgary Alberta Canada|
Departments of Neurology and Pediatrics Johns Hopkins Outpatient Center Baltimore Maryland U.S.A..
The Charlie Foundation Santa Monica California U.S.A
Department of Pediatric Neurology CHU Hôpital Robert Debré Paris France
Department of Neurology and Pediatrics Montefiore Medical Center/Albert Einstein College of Medicine Bronx New York U.S.A
Department of Neurology The Childrens Hospital of Philadelphia Philadelphia Pennsylvania U.S.A
Department of Nutrition Lurie Children's Hospital Chicago Illinois U.S.A
Department of Pediatrics Alberta Children's Hospital Calgary Alberta Canada
Department of Neurology Hospital J P Garrahan, Capital Federal Buenos Aires Argentina
Department of Clinical & Experimental Epilepsy Great Ormond Street Hospital University College London London United Kingdom
Department of Clinical Neuroscience, Women's and Children's Health Karolinska Institute Stockholm Sweden
Division of Neurology The Hospital for Sick Children Toronto Ontario Canada
Department of Pediatric Neurology Izmir Dr. Behcet Uz Children's Hospital Izmir Turkey
Department of Neurology Montefiore Medical Center Bronx New York U.S.A
Department of Pediatrics and Neuropediatrics Children's Hospital Aschaffenburg Aschaffenburg Germany
Department of Pediatrics Pediatric Epilepsy Clinic Severance Children's Hospital Seoul Korea
Department of Neurology Epilepsy Centre Kempenhaeghe Heeze The Netherlands
Department of Neurology The Hospital for Sick Children Toronto Ontario Canada
Department of Child Neurology Shushrusha Hospital Mumbai India
Department of Neurology Children's Hospital of Los Angeles Los Angeles California U.S.A..
Department of Neurology Massachusetts General Hospital Boston Massachusetts U.S.A..
Epilepsy Research Centre, Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Department of Pediatrics Lady Hardinge Medical College New Delhi India..
Departments of Pediatrics and Neurology Johns Hopkins Hospital Baltimore Maryland U.S.A
Department of Pediatrics The Johns Hopkins University Baltimore Maryland U.S.A
Department of Neurology Hospital Italiano de Buenos Aires Buenos Aires Argentina
Department of Dietetics Sophia Children's Hospital Erasmus Medical Centre Rotterdam The Netherlands
Infantile Neuropsychiatry Neurological Institute Foundation Casimiro Mondino Pavia Italy
Department of Pediatric Neurology University of Tennessee Memphis Tennessee U.S.A
Department of Neurology, Child and Adolescent Neurology Mayo Clinic Rochester Minnesota U.S.A
|Citation:||Epilepsia open 2018; 3(2): 175-192|
|Abstract:||Ketogenic dietary therapies (KDTs) are established, effective nonpharmacologic treatments for intractable childhood epilepsy. For many years KDTs were implemented differently throughout the world due to lack of consistent protocols. In 2009, an expert consensus guideline for the management of children on KDT was published, focusing on topics of patient selection, pre-KDT counseling and evaluation, diet choice and attributes, implementation, supplementation, follow-up, side events, and KDT discontinuation. It has been helpful in outlining a state-of-the-art protocol, standardizing KDT for multicenter clinical trials, and identifying areas of controversy and uncertainty for future research. Now one decade later, the organizers and authors of this guideline present a revised version with additional authors, in order to include recent research, especially regarding other dietary treatments, clarifying indications for use, side effects during initiation and ongoing use, value of supplements, and methods of KDT discontinuation. In addition, authors completed a survey of their institution's practices, which was compared to responses from the original consensus survey, to show trends in management over the last 10 years.|
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.